A. A. Smorodintsev
About
In The Last Decade
A. A. Smorodintsev
37 papers receiving 419 citations
Peers
Comparison fields: 5 of 55
- Epidemiology 378
- Infectious Diseases 167
- Immunology 105
- Agronomy and Crop Science 98
- Molecular Biology 59
Countries citing papers authored by A. A. Smorodintsev
This map shows the geographic impact of A. A. Smorodintsev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. A. Smorodintsev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. A. Smorodintsev more than expected).
Fields of papers citing papers by A. A. Smorodintsev
This network shows the impact of papers produced by A. A. Smorodintsev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. A. Smorodintsev. The network helps show where A. A. Smorodintsev may publish in the future.
Co-authorship network of co-authors of A. A. Smorodintsev
This figure shows the co-authorship network connecting the top 25 collaborators of A. A. Smorodintsev. A scholar is included among the top collaborators of A. A. Smorodintsev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. A. Smorodintsev. A. A. Smorodintsev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [Live enteroviral vaccines for the emergency nonspecific prevention of mass respiratory diseases during fall-winter epidemics of influenza and acute respiratory diseases]. | 34 |
| 2 | 6 | |
| 3 | Antigenic relationships between strains of influenza B virus. | 4 |
| 4 | Studies on the use of interferon inducers in man and animals. | 3 |
| 5 | 183 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | Experience with live rubella virus vaccine combined with live vaccines against measles and mumps. | 17 |
| 10 | [The nature of cells elaborating interferon]. | 1 |
| 11 | 7 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | Obtaining of an Additionally Attenuated Vaccinating Cryophil Influenza Strain. | 15 |
| 15 | The Mechanism of Enhanced Activity of Anti-Influenza Virus Neutralizing Antisera on their Interaction with Native Serum from Normal Animals. | 3 |
| 16 | Intensity of the Interaction of Antibody and Virus in the Haemagglutination Inhibition Test in the Presence of Nonspecific Thermolabile Stimulator of Antibodies. | 2 |
| 17 | Evaluation of the Epidemiological Effectiveness of Live Influenza Vaccine during the Type A2 and B Epidemics of 1959. | 1 |
| 18 | Electrophoretic Investigations on Thermostable Inhibitors of Type A2 Influenza Virus in Normal Animal Sera. | 3 |
| 19 | Peculiarities of the Interaction of Thermostable Inhibitors from Normal Sera with Type A2 Influenza Viruses of the 1957, Pandemic. | 2 |
| 20 | Haemorrhagic Nephroso-Nephritis. | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.